Clinical trial
Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment…
NCT00325390 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00325390 |
|---|---|
| Title | Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation |
| Official title | Double-Blind Parallel Comparison Study of SR25990C Versus Standard Therapy in Japan(Ticlopidine) in Patients With Acute Coronary Syndrome Without ST-Segment Elevation Who Are Planned for Percutaneous Coronary Intervention |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Daiichi Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Platelet Aggregation Inhibitors, NSTEACS |
| Intervention type | Drug |
| Interventions | clopidogrel (SR25990C) |
| Enrollment | 800 |
| Start date | Jul 1, 2004 |
| First posted | May 12, 2006 |
| Last update posted | Mar 25, 2009 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: